YMC America, Inc.

YMC America Continues to Improve Purification Processes in Large-Scale Production Implementations

For over four decades, YMC has striven to provide solutions to biopharmaceutical and pharmaceutical companies that utilize purification processes in the development of drug therapies. The need for a cost-effective approach to purification is essential to increase yields and reach target purity levels.

YMC Completes First Phase of Operational Growth Plan in USA

YMC America has recently completed the successful co-location and expansion of its US business operations at its growing campus in Devens, Massachusetts.

YMC-Triart Prep Phenyl-S Separation Media Is Designed for Peptide Purification

YMC-Triart is a widely-utilized family of stationary phases for HPLC and Prep LC. YMC has recently developed a YMC-Triart phase ideal for peptides with aromatic residues.

Cost and Processing Time Reductions for Insulin Purification Achieved with YMC-Triart Stationary Phase

Insulin is a peptide hormone. Due to the typical scale of insulin production and market pressures to increase availability and reduce the cost of insulin, there is justification to invest resources into finding improved conditions and materials for insulin purification.

YMC Offers Hydrophobic Interaction Chromatography (HIC) Column for Monoclonal Antibodies

Hydrophobic interaction chromatography (HIC) is often useful for antibody separations because running conditions are non-denaturing, and differences in protein surface-associated hydrophobicity offer high selectivity.

YMC Application Note Discusses Scale Up of Peptide Purification

YMC's three-page Application Note highlights the practical steps of method development and scale up for the reversed-phase LC purification of the therapeutic peptide, liraglutide. The Application Note is entitled: Purification of Peptides with Full Flexibility.

YMC Announces Formal Study of Large-Scale Production of Specialty Peptide Drug API with Continuous Chromatography System

PeptiDream and YMC groups announce a formal joint-task group to scale successful lab work to multiple GMP production lines for specialty peptide drug products at the main factory of PeptiStar Inc. YMC’s patented twin-column technology will be a key technology in the venture. Work is anticipated to result in the implementation of the technology on a large scale in late 2021.

YMC-Triart Guard Columns for HPLC and UHPLC Chromatography

Guard columns offer important functions in liquid chromatography. Guard columns protect the analytical column from contamination or damage, resulting in longer column life.

YMC Technical Note Provides Insights to Improve Peptide Purification

YMC's four-page Technical Note provides practical guidance for the development and improvement of methods for peptide purification. The Technical Note is entitled: How to improve a peptide purification process.

Business Growth Precipitates Consolidation and Expansion Opportunities at YMC in USA

YMC plans expansion of lab development services and consolidation of its Allentown, PA, location into its larger Devens, MA, facility. The new location will facilitate an increase in customer services and a larger site staff to support the future growth of consumable products.